Allergic diseases diagnosis and treatment

Group leader

Belén de la Hoz Caballer

alergiaramonycajal(ELIMINAR)@gmail.com

913368340 / 913368864

Principal Investigator

  • Maria Pilar Berges Gimeno

Collaborating Staff

  • Lorena Bernal Rubio
  • María Pia de Calzada Bustingorri
  • David González de Olano
  • Francisco Javier Sola Martínez
  • Carmen Vidal Albareda
  • Alicia Barra Castro
  • Ana de Andrés Martín
  • Cristina Pueyo Lopez
  • Darío Antolín Amérigo
  • Cristiana Lucia Solorzano Zepeda
  • Laura Gisella Díaz Montalvo
  • María Carmen Diéguez Pastor
  • José María Renilla Arroyo
  • Almudena Gómez Mena
  • Hana Cho Park
  • Luis Carrasco Gómez
  • Cristina Mato de Prada
  • Elena Ramirez Mateo
  • Laura Victoria Carpio Escalona
Imagen equipo

Group leader

Belén de la Hoz Caballer

alergiaramonycajal(ELIMINAR)@gmail.com

913368340 / 913368864

Principal Investigator

  • Maria Pilar Berges Gimeno

Collaborating Staff

  • Lorena Bernal Rubio
  • María Pia de Calzada Bustingorri
  • David González de Olano
  • Francisco Javier Sola Martínez
  • Carmen Vidal Albareda
  • Alicia Barra Castro
  • Ana de Andrés Martín
  • Cristina Pueyo Lopez
  • Darío Antolín Amérigo
  • Cristiana Lucia Solorzano Zepeda
  • Laura Gisella Díaz Montalvo
  • María Carmen Diéguez Pastor
  • José María Renilla Arroyo
  • Almudena Gómez Mena
  • Hana Cho Park
  • Luis Carrasco Gómez
  • Cristina Mato de Prada
  • Elena Ramirez Mateo
  • Laura Victoria Carpio Escalona

STRATEGIC OBJECTIVES

  • To identify biomarkers, based on B cell epitopes and microRNA expression, to improve the diagnosis and treatment of food allergies.
  • To measure the quality of life and socioeconomic costs associated with food allergies.
  • To develop technological tools for monitoring patients with food allergies undergoing immunotherapy.
  • To evaluate the usefulness of in vitro basophil activation and interleukin determination techniques for the diagnosis and monitoring of desensitization treatment with chemotherapy and biologics.
  • To study the quality of life and costs of drug desensitization procedures.
  • To evaluate the frequency of mast cell disease in patients with anaphylaxis.
  • To assess risk factors in severe asthma.
  • To perform technological and clinical validation of a respiratory exposure chamber for aeroallergens.

RESEARCH LINES

  • Respiratory allergy.
  • Anaphylaxis and mastocytosis.
  • Diagnosis and treatment of allergy to chemotherapy and biologic drugs.
  • Diagnosis and treatment of food allergy.

Location

Ramón y Cajal University Hospital

Allergy Department
2nd Floor, Left

Keywords

Allergy, B epitopes, IgE, foods, medications, desensitization, chemotherapy, monoclonal, oral food immunotherapy, environmental allergen immunotherapy, mastocytosis, biomarkers, severe asthma, urticaria, quality of life, hymenoptera, molecular diagnosis, microarrays, tryptase, anaphylaxis